Avacopan Improves Kidney Health in ANCA-Associated Vasculitis with eGFRs Less than 20
Data from patients with eGFR of 20 mL/min/1.73m2 or less from the ADVOCATE trial provide new insight into the effects of avacopan use in patients with lower baseline eGFRs.
Source: hcplive.com